EA199900374A1 - Ингибитор вторичной катаракты - Google Patents

Ингибитор вторичной катаракты

Info

Publication number
EA199900374A1
EA199900374A1 EA199900374A EA199900374A EA199900374A1 EA 199900374 A1 EA199900374 A1 EA 199900374A1 EA 199900374 A EA199900374 A EA 199900374A EA 199900374 A EA199900374 A EA 199900374A EA 199900374 A1 EA199900374 A1 EA 199900374A1
Authority
EA
Eurasian Patent Office
Prior art keywords
secondary cataract
cataract inhibitor
inhibitor
inhibiting
prevention
Prior art date
Application number
EA199900374A
Other languages
English (en)
Other versions
EA001745B1 (ru
Inventor
Масаюки Исадзи
Хироси Мията
Юкиеси Адзисава
Original Assignee
Киссеи Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Киссеи Фармасьютикал Ко., Лтд. filed Critical Киссеи Фармасьютикал Ко., Лтд.
Publication of EA199900374A1 publication Critical patent/EA199900374A1/ru
Publication of EA001745B1 publication Critical patent/EA001745B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Ингибитор вторичной катаракты, содержащий в качестве активного ингредиента N-(3,4-диметоксициннамоил) антраниловую кислоту, представленную формулой (I)или ее фармацевтически приемлемую соль, эффективен в ингибировании, например, помутнения задней капсулы после операции на катаракте, его можно использовать для профилактики или лечения вторичной катаракты.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900374A 1996-10-14 1997-10-09 Ингибитор вторичной катаракты EA001745B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30695296 1996-10-14
PCT/JP1997/003630 WO1998016214A1 (fr) 1996-10-14 1997-10-09 Inhibiteur de la cataracte secondaire

Publications (2)

Publication Number Publication Date
EA199900374A1 true EA199900374A1 (ru) 1999-12-29
EA001745B1 EA001745B1 (ru) 2001-08-27

Family

ID=17963256

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900374A EA001745B1 (ru) 1996-10-14 1997-10-09 Ингибитор вторичной катаракты

Country Status (14)

Country Link
US (1) US6376543B1 (ru)
EP (1) EP0958815A4 (ru)
KR (1) KR20000049136A (ru)
CN (1) CN1111403C (ru)
AU (1) AU745028B2 (ru)
BR (1) BR9712308A (ru)
CA (1) CA2267320A1 (ru)
CZ (1) CZ127999A3 (ru)
EA (1) EA001745B1 (ru)
HU (1) HUP9904617A3 (ru)
IL (1) IL129421A0 (ru)
NO (1) NO991627L (ru)
NZ (1) NZ335042A (ru)
WO (1) WO1998016214A1 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2286120A1 (en) * 1997-04-18 1998-10-29 Kissei Pharmaceutical Co., Ltd. Preventives or remedies for diseases affecting excessive proliferation of retinal pigment epithelial cells
US20060172972A1 (en) * 2002-12-20 2006-08-03 Chakshu Research Inc Formulation and method for administration of ophthalmologically active agents
US20060166879A1 (en) * 2002-12-20 2006-07-27 Chakshu Research Inc Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
US20060177430A1 (en) * 2002-12-20 2006-08-10 Chakshu Research Inc Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
WO2004058289A1 (en) * 2002-12-20 2004-07-15 Chakshu Research, Inc. Ophthalmic formulation for the prevention and treatment of ocular conditions
US20050106230A1 (en) * 2003-11-17 2005-05-19 Young Janel E. Drug-enhanced adhesion prevention
WO2006073126A1 (ja) * 2005-01-06 2006-07-13 Kissei Pharmaceutical Co., Ltd. 慢性移植片対宿主症におけるドライアイの予防および治療剤
WO2007011843A2 (en) * 2005-07-15 2007-01-25 Chakshu Research Inc. Prevention and treatment of ophthalmic complications of diabetes
CA2670590C (en) * 2006-12-01 2018-06-12 Wake Forest University Health Sciences Medical devices incorporating collagen inhibitors
WO2008144933A1 (en) 2007-05-29 2008-12-04 Université de Montréal Cinnamoyl inhibitors of transglutaminase
NZ597573A (en) * 2009-07-02 2013-10-25 Oxigene Inc Combretastatins for prevention of posterior capsule opacification
US9844556B2 (en) 2015-03-25 2017-12-19 Megumi Honjo Preventive/therapeutic method and preventive/therapeutic agent for complications after cataract surgery
RU2622606C1 (ru) * 2016-08-11 2017-06-16 Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ медикаментозного лечения вторичной катаракты

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07116029B2 (ja) * 1989-04-04 1995-12-13 キッセイ薬品工業株式会社 トラニラスト水溶液製剤
FR2693107B1 (fr) * 1992-07-01 1994-09-23 Chauvin Laboratoire Moyens pour la prévention de la cataracte secondaire.
DE69434617D1 (de) * 1993-11-19 2006-04-06 Univ Sydney Verfahren zur prophylaxe oder kontrolle des katarakts
KR19990082523A (ko) * 1996-02-15 1999-11-25 간자와 무츠와 혈관생성 억제제

Also Published As

Publication number Publication date
HUP9904617A3 (en) 2000-07-28
CN1233172A (zh) 1999-10-27
EP0958815A1 (en) 1999-11-24
NO991627L (no) 1999-06-03
EP0958815A4 (en) 2001-02-07
CN1111403C (zh) 2003-06-18
AU4471897A (en) 1998-05-11
HUP9904617A2 (hu) 2000-05-28
CA2267320A1 (en) 1998-04-23
AU745028B2 (en) 2002-03-07
IL129421A0 (en) 2000-02-17
WO1998016214A1 (fr) 1998-04-23
BR9712308A (pt) 1999-08-31
NZ335042A (en) 2001-01-26
KR20000049136A (ko) 2000-07-25
US6376543B1 (en) 2002-04-23
CZ127999A3 (cs) 1999-07-14
NO991627D0 (no) 1999-04-06
EA001745B1 (ru) 2001-08-27

Similar Documents

Publication Publication Date Title
ATE223378T1 (de) Prolineamid-derivate
NO903438D0 (no) Fremgangsmaate for fremstilling av tiazolderivater.
DE69604714T2 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
MXPA04001253A (es) Derivados de acidos carboxilicos y agente farmaceutico que comprende los mismos como ingrediente activo.
EA199900374A1 (ru) Ингибитор вторичной катаракты
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
EA200200619A1 (ru) Непептидильные ингибиторы vla-4-зависимого связывания клеток, применяемые при лечении воспалительных, аутоимунных и респираторных заболеваний
DK0880508T3 (da) Quinazolinderivater som VEGF-inhibitorer
PT842923E (pt) Derivados do pirrolo e composicoes medicinais
EA200101077A1 (ru) Композиция для профилактики или лечения слабоумия, включающая производное гидроксикоричной кислоты или экстракт растения рода angelicae, содержащий его
DK0579833T3 (da) Ethanolaminderivater med anti-pollakisuria-virkning
ES2105286T3 (es) Derivados de etanolamina que tienen actividades simpatomimetica y anti-polaquiuria.
EA199800721A1 (ru) Ингибитор реваскуляризации
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
EA200200489A1 (ru) Новые соединения бензотиадиазина, способ их получения и содержащие их фармацевтические композиции
ES2104370T3 (es) Derivados de (arilalquilaminobencil)aminopropionamidas sustituidas, su preparacion y utilizacion.
ES2191763T3 (es) Inhibidor del desarrollo de dependencia/tolerancia a un agente analgesico narcotico.
ATE235900T1 (de) Hemmer der subepithelialen turbidität
JPS5731616A (en) Relaxing agent for muscle comprising benzofurancarboxylic acid amide
IL58999A0 (en) Pharmaceutical compositions comprising certain imidazolinederivatives
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
DE69614508T2 (de) Thiol derivate mit metallopeptidase inhibierender aktivitat
WO2002096359A3 (en) Piperazine pentanamide hiv protease inhibitors
EA199800033A1 (ru) Антагонисты канала кальция
EA199800575A1 (ru) Производные пиперазина

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU